(Total Views: 42)
Posted On: 08/25/2025 12:14:53 PM
Post# of 25747

$ADTX Aditxt subsidiary targets early 2026 FDA submission for immune therapy
https://www.investing.com/news/company-news/i...CH-4208890
https://www.investing.com/news/company-news/i...CH-4208890

